litlas
Log inCreate account

John D. Shaughnessy

Active 1990–2025

116
Papers
27,706
Citations
90
h-index
111
i10-index

Citations

Citations per year for John D. Shaughnessy1986: 1 citations1993: 9 citations1994: 2 citations1996: 4 citations1997: 47 citations1998: 31 citations1999: 45 citations2000: 36 citations2001: 83 citations2002: 109 citations2003: 152 citations2004: 184 citations2005: 251 citations2006: 237 citations2007: 356 citations2008: 358 citations2009: 456 citations2010: 422 citations2011: 511 citations2012: 399 citations2013: 347 citations2014: 322 citations2015: 273 citations2016: 228 citations2017: 243 citations2018: 196 citations2019: 576 citations2020: 565 citations2021: 618 citations2022: 383 citations2023: 221 citations2024: 400 citations2025: 162 citations2026: 3 citations1987–1992: no citations, so these years are not shown1995: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,781 citing papers, 31.6% of this breakdownChina: 697 citing papers, 7.9% of this breakdownGermany: 546 citing papers, 6.2% of this breakdownItaly: 537 citing papers, 6.1% of this breakdownUnited Kingdom: 476 citing papers, 5.4% of this breakdownFrance: 433 citing papers, 4.9% of this breakdownCanada: 319 citing papers, 3.6% of this breakdownSpain: 315 citing papers, 3.6% of this breakdownNetherlands: 256 citing papers, 2.9% of this breakdownJapan: 236 citing papers, 2.7% of this breakdownAustralia: 188 citing papers, 2.2% of this breakdownGreece: 160 citing papers, 1.8% of this breakdown
0%31.6%Other 21.1%

Institutions

Fields

  • Medicine53%
  • Biochemistry, Genetics and Molecular Biology33.8%
  • Immunology and Microbiology6.4%
  • Neuroscience2.4%
  • Computer Science1.6%
  • Engineering1.2%
  • Other1.6%

Topics

  • Multiple Myeloma Research and Treatments12.2%
  • Protein Degradation and Inhibitors5.1%
  • Peptidase Inhibition and Analysis3%
  • Ubiquitin and proteasome pathways2.7%
  • Immune Cell Function and Interaction2%
  • Bone health and treatments1.9%
  • Other73.1%

Coauthors

All papers

Open in search
  1. The molecular classification of multiple myeloma

    Authors: Fenghuang Zhan, Yongsheng Huang, Simona Colla, Peter Stewart, Ichiro Hanamura, Sushil Gupta, Joshua Epstein, Shmuel Yaccoby, Jeffrey R. Sawyer, Bart Burington, Elias Anaissie, Klaus Hollmig, Mauricio Pineda‐Roman, Guido Tricot, Frits van Rhee, Ronald C. Walker, Maurizio Zangari, John Crowley, Bart Barlogie, John D. Shaughnessy - Blood 2006 cited by 1,142

  2. The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models

    Authors: Brett T. Thorn, Zhichao Liu, Stephen Harris, Baitang Ning, Lei Xu, Lun Yang, Huixiao Hong, Jie Liu, Zhiguang Li, James C. Fuscoe, Leming Shi, Qiang Shi, Weigong Ge, Min Zhang, Minjun Chen, Roger Perkins, Zhining Wen, Weida Tong, Reena Philip, Uwe Scherf, Francisco Martínez-Murillo, Rong Tang, Gene Pennello, Brandon D. Gallas, Gregory Campbell, Lakshmi Vishnuvajjala, F. W. Samuelson, Živana Težak, Weijie Chen, Wendell Jones, Joel S. Parker, Fabien Campagne, Stephen J. Walker, Zhenqiang Su, Joshua Xu, Hong Fang, Feng Qian, Dhivya Arasappan, Zhenqiang Su, Russell D. Wolfinger, Padraic Neville, Tzu‐Ming Chu, Li Li, Wenjun Bao, Kelci Miclaus, Pei-Yi Tan, Wendy Czika, Federico Goodsaid, Mat Soukup, Li Zhang, Jialü Zhang, Sue Jane Wang, Lajos Pusztai, John D. Shaughnessy, Bart Barlogie, Yiming Zhou, Matthias Fischer, André Oberthuer, Yvonne Kahlert, Frank Berthold, Russell S. Thomas, J.-H Chou, Richard S. Paules, Jennifer Fostel, Pierre R. Bushel, Mark R. Fielden, Pan Du, Simon Lin, Cesare Furlanello, Giuseppe Jurman, Samantha Riccadonna, Roberto Visintainer, Xijin Ge, Dalila B. Megherbi, Manuel Madera, W. Fraser Symmans, May D. Wang, R. Mitchell Parry, Todd H. Stokes, John H. Phan, Andrea B. Moffitt, Jun Luo, John H. Zhang, Matthew Woods, Eric W. Wang, Hans Bitter, Dilafruz Juraeva, Benedikt Brors, Frank Westermann, Roland Eils, Johan Trygg, Max Bylesjö, Jie Cheng, Jing Cheng, Timothy S. Davison, Mauro Delorenzi, Vlad Popovici, Youping Deng, Viswanath Devanarayan, Richard Judson and 101 more - Nature Biotechnology 2010 cited by 915

  3. CS1, a Potential New Therapeutic Antibody Target for the Treatment of Multiple Myeloma

    Authors: Eric D. Hsi, Roxanne Steinle, Balaji Balasa, Susann Szmania, Aparna Draksharapu, Benny P. Shum, Mahrukh Huseni, David B. Powers, Amulya Nanisetti, Yin Zhang, Audie Rice, Anne van Abbema, Melanie Wong, Gao Liu, Fenghuang Zhan, Myles Dillon, Shihao Chen, Susan Rhodes, Franklin Fuh, Naoya Tsurushita, Shankar Kumar, Vladimir Vexler, John D. Shaughnessy, Bart Barlogie, Frits van Rhee, Mohamad A. Hussein, Daniel Afar, Marna Williams - Clinical Cancer Research 2008 cited by 560

  4. A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1

    Authors: John D. Shaughnessy, Fenghuang Zhan, Bart Burington, Yongsheng Huang, Simona Colla, Ichiro Hanamura, Peter Stewart, Bob Kordsmeier, Christopher E. Randolph, David R. Williams, Yan Xiao, Hongwei Xu, Joshua Epstein, Elias Anaissie, Somashekar G. Krishna, Michele Cottler‐Fox, Klaus Hollmig, Abid Mohiuddin, Mauricio Pineda‐Roman, Guido Tricot, Frits van Rhee, Jeffrey R. Sawyer, Yazan Alsayed, Ronald C. Walker, Maurizio Zangari, John Crowley, Bart Barlogie - Blood 2006 cited by 916

  5. Frequent gain of chromosome band 1q21 in plasma-cell dyscrasias detected by fluorescence in situ hybridization: incidence increases from MGUS to relapsed myeloma and is related to prognosis and disease progression following tandem stem-cell transplantation

    Authors: Ichiro Hanamura, Peter Stewart, Yongsheng Huang, Fenghuang Zhan, Madhumita Santra, Jeffrey R. Sawyer, Klaus Hollmig, Maurizio Zangarri, Mauricio Pineda‐Roman, Frits van Rhee, Federica Cavallo, Bart Burington, John Crowley, Guido Tricot, Bart Barlogie, John D. Shaughnessy - Blood 2006 cited by 479

  6. The Role of the Wnt-Signaling Antagonist DKK1 in the Development of Osteolytic Lesions in Multiple Myeloma

    Authors: Erming Tian, Fenghuang Zhan, Ronald C. Walker, Erik Rasmussen, Yupo Ma, Bart Barlogie, John D. Shaughnessy - New England Journal of Medicine 2003 cited by 1,505

  7. Frequent Engagement of the Classical and Alternative NF-κB Pathways by Diverse Genetic Abnormalities in Multiple Myeloma

    Authors: Christina M. Annunziata, R. Eric Davis, Yulia N. Demchenko, William Bellamy, Ana Gabrea, Fenghuang Zhan, Georg Lenz, Ichiro Hanamura, George W. Wright, Wenming Xiao, Sandeep S. Davé, Elaine M. Hurt, Bruce K. Tan, Hong Zhao, Owen Stephens, Madhumita Santra, David R. Williams, Lenny Dang, Bart Barlogie, John D. Shaughnessy, W. Michael Kuehl, Louis M. Staudt - Cancer Cell 2007 cited by 949

  8. F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma

    Authors: Twyla B. Bartel, Jeff Haessler, Tracy L. Brown, John D. Shaughnessy, Frits van Rhee, Elias Anaissie, Terri L. Alpe, Edgardo Angtuaco, Ronald C. Walker, Joshua Epstein, John Crowley, Bart Barlogie - Blood 2009 cited by 523

  9. Geographic and Racial Disparities in Access to Chimeric Antigen Receptor–T Cells and Bispecific Antibodies Trials for Multiple Myeloma

    Authors: Raghad Abdelqader Al-Qazaqi, Carolina Schinke, Sharmilan Thanendrarajan, Maurizio Zangari, John D. Shaughnessy, Fenghuang Zhan, Guido Tricot, Frits van Rhee, Samer Al Hadidi - JAMA Network Open 2022 cited by 59

  10. Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma

    Authors: P. Leif Bergsagel, W. Michael Kuehl, Fenghuang Zhan, Jeffrey R. Sawyer, Bart Barlogie, John D. Shaughnessy - Blood 2005 cited by 695

  11. Bispecific BCMA/CD24 CAR-T cells control multiple myeloma growth

    Authors: Fumou Sun, Yan Cheng, Visanu Wanchai, Wancheng Guo, David E. Mery, Hongwei Xu, Dongzheng Gai, Eric R. Siegel, Clyde Bailey, Cody Ashby, Samer Al Hadidi, Carolina Schinke, Sharmilan Thanendrarajan, Yupo Ma, Qing Yi, Robert Z. Orlowski, Maurizio Zangari, Frits van Rhee, Siegfried Janz, Gail A. Bishop, Guido Tricot, John D. Shaughnessy, Fenghuang Zhan - Nature Communications 2024 cited by 43

  12. The role of Dickkopf-1 in bone development, homeostasis, and disease

    Authors: Joseph J. Pinzone, Brett M. Hall, Nanda K. Thudi, Martin Vonau, Ya‐Wei Qiang, Thomas J. Rosol, John D. Shaughnessy - Blood 2008 cited by 403

  13. Gene expression profiling and correlation with outcome in clinical trials of the proteasome inhibitor bortezomib

    Authors: George Mulligan, Constantine S. Mitsiades, Barbara M. Bryant, Fenghuang Zhan, Wee Joo Chng, Steven Roels, Erik Koenig, Andrew Fergus, Yongsheng Huang, Paul G. Richardson, William L. Trepicchio, Annemiek Broyl, Pieter Sonneveld, John D. Shaughnessy, P. Leif Bergsagel, David P. Schenkein, Dixie‐Lee Esseltine, Anthony Boral, Kenneth C. Anderson - Blood 2006 cited by 421

  14. Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosis

    Authors: Fenghuang Zhan, Bart Barlogie, Varant Arzoumanian, Yongsheng Huang, David R. Williams, Klaus Hollmig, Mauricio Pineda‐Roman, Guido Tricot, Frits van Rhee, Maurizio Zangari, Madhav V. Dhodapkar, John D. Shaughnessy - Blood 2006 cited by 383

  15. Magnetic Resonance Imaging in Multiple Myeloma: Diagnostic and Clinical Implications

    Authors: Ronald C. Walker, Bart Barlogie, Jeffrey Haessler, Guido Tricot, Elias Anaissie, John D. Shaughnessy, Joshua Epstein, Rudy Van Hemert, Erdem Eren, Antje Hoering, John Crowley, Ernest J. Ferris, Klaus Hollmig, Frits van Rhee, Maurizio Zangari, Mauricio Pineda‐Roman, Abid Mohiuddin, Shmuel Yaccoby, Jeffrey R. Sawyer, Edgardo J. Angtuaco - Journal of Clinical Oncology 2007 cited by 417

  16. TRIP13 modulates protein deubiquitination and accelerates tumor development and progression of B cell malignancies

    Authors: Can Li, Jiliang Xia, Reinaldo Franqui-Machin, Fangping Chen, Yanjuan He, Cody Ashby, Feixiang Teng, Hongwei Xu, Dingxiao Liu, Dongzheng Gai, Sadie Johnson, Frits van Rhee, Siegfried Janz, John D. Shaughnessy, Guido Tricot, Ivana Frech, Fenghuang Zhan - Journal of Clinical Investigation 2021 cited by 42

  17. AKT supports the metabolic fitness of multiple myeloma cells by restricting FOXO activity

    Authors: Timon A. Bloedjes, Guus de Wilde, Gerarda H. Khan, Timothy C. Ashby, John D. Shaughnessy, Fenghuang Zhan, Riekelt H. Houtkooper, Richard J. Bende, Carel J.M. van Noesel, Marcel Spaargaren, Jeroen E. J. Guikema - Blood Advances 2022 cited by 20

  18. International Myeloma Working Group molecular classification of multiple myeloma: spotlight review

    Authors: Rafaël Fonseca, P. Leif Bergsagel, Johannes Drach, John D. Shaughnessy, Norma C. Gutiérrez, A. Keith Stewart, Gareth J. Morgan, Brian Van Ness, Marta Chesi, Stéphane Minvielle, Antonino Neri, Bart Barlogie, W. Michael Kuehl, Peter Liebisch, Faith E. Davies, Selina Chen‐Kiang, Brian G.M. Durie, Ruben D. Carrasco, Orhan Sezer, Tony Reiman, Linda M. Pilarski, Hervé Avet‐Loiseau - Leukemia 2009 cited by 878

  19. Heparanase Enhances Syndecan-1 Shedding

    Authors: Yang Yang, Veronica MacLeod, Hua‐Quan Miao, Allison Theus, Fenghuang Zhan, John D. Shaughnessy, Jeffrey R. Sawyer, Jin‐Ping Li, Eyal Zcharia, Israël Vlodavsky, Ralph D. Sanderson - Journal of Biological Chemistry 2007 cited by 263

  20. Gene expression profiling of plasma cells and plasmablasts: toward a better understanding of the late stages of B-cell differentiation

    Authors: Karin Tarte, Fenghuang Zhan, John De Vos, Bernard Klein, John D. Shaughnessy - Blood 2003 cited by 216

  21. The sumoylation pathway is dysregulated in multiple myeloma and is associated with adverse patient outcome

    Authors: James J. Driscoll, Dheeraj Pelluru, Konstantinos Lefkimmiatis, Mariateresa Fulciniti, Rao Prabhala, Philip R. Greipp, Bart Barlogie, Yu‐Tzu Tai, Kenneth C. Anderson, John D. Shaughnessy, Christina M. Annunziata, Nikhil C. Munshi - Blood 2009 cited by 126

  22. Absence Epilepsy in Tottering Mutant Mice Is Associated with Calcium Channel Defects

    Authors: Colin Fletcher, Cathleen Lutz, T. Norene O’Sullivan, John D. Shaughnessy, Richard Hawkes, Wayne N. Frankel, Neal G. Copeland, Nancy A. Jenkins - Cell 1996 cited by 782

  23. Thalidomide and Hematopoietic-Cell Transplantation for Multiple Myeloma

    Authors: Bart Barlogie, Guido Tricot, Elias Anaissie, John D. Shaughnessy, Erik Rasmussen, Frits van Rhee, Athanasios Fassas, Maurizio Zangari, Klaus Hollmig, Mauricio Pineda‐Roman, Choon Lee, Giampaolo Talamo, Raymond Thertulien, Elias Kiwan, Somashekar G. Krishna, M. Fox, John Crowley - New England Journal of Medicine 2006 cited by 739

  24. Proliferation is a central independent prognostic factor and target for personalized and risk-adapted treatment in multiple myeloma

    Authors: Dirk Hose, Thierry Rème, Thomas Hielscher, Jérôme Moreaux, Torbjörn Messner, Anja Seckinger, Axel Benner, John D. Shaughnessy, Bart Barlogie, Yiming Zhou, Jens Hillengaß, Uta Bertsch, Kai Neben, Th. Möhler, Jean‐François Rossi, A. Jauch, Barbara Klein, H. Goldschmidt - Haematologica 2010 cited by 201